{
  "report_rows": [
    {
      "kpi": "Net New R&DS Bookings / B2B",
      "prediction": "BEAT",
      "answer": "pred ~$2,875M / 1.16x vs cons $2,720M / 1.081x",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Total Revenue (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$4,345M vs cons $4,302M",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adj. Diluted EPS (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$3.10 vs cons $3.031",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY 2026 Adj. EPS (FY2026)",
      "prediction": "BETTER",
      "answer": "guide ~$13.10 mid vs cons $12.81",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY 2026 Revenue (FY2026)",
      "prediction": "BETTER",
      "answer": "guide ~$17,400M mid vs cons $17,296M",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Bookings/B2B tone (FY2026)",
      "prediction": "BETTER",
      "answer": "double-digit growth reaffirmed, EBP at record levels vs cons 1.142x",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 8.0,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 5.0,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "FOLLOW-THROUGH \u2014 sell-side revises H2 EPS up on implied out-period math improvement; bookings beat pulls forward multiple",
  "day5_confidence": "MEDIUM"
}